Coronary artery calcium (CAC) scoring was disproportionately less reliable as a screen for atherosclerotic plaque for people of certain races and countries, according to the large international study ...
Could showing someone a picture of plaque building up in their arteries be enough to save their life? That's the question driving the latest research by the University of Tasmania's Menzies Institute ...
For years, most of us have been taught to think about heart health in silos. Cholesterol here, blood pressure there, and ...
In high-risk patients with diabetes but without known atherosclerosis, evolocumab reduced risk for a first major CV event compared with placebo, according to a subgroup analysis of the VESALIUS-CV ...
The cholesterol-lowering therapy evolocumab reduced the risk of major adverse cardiac events by nearly one-third among patients who had no known significant atherosclerosis and had diabetes, according ...
Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results